➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Last Updated: June 25, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Omiganan

Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Omiganan?

Omiganan is an investigational drug.

There have been 13 clinical trials for Omiganan. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2015.

The most common disease conditions in clinical trials are Rosacea, Dermatitis, and Eczema. The leading clinical trial sponsors are Cutanea Life Sciences, Inc., Mallinckrodt, and Leiden University Medical Center.

Recent Clinical Trials for Omiganan
Omiganan Twice a Day (BID) in Patients With Facial Seborrheic DermatitisCutanea Life Sciences, Inc.Phase 2
Pharmacodynamics of Omiganan BID in Patients With Atopic DermatitisCutanea Life Sciences, Inc.Phase 2
Topical Challenge With Omiganan and Imiquimod in Healthy VolunteersCutanea Life Sciences, Inc.Phase 1

See all Omiganan clinical trials

Clinical Trial Summary for Omiganan

Top disease conditions for Omiganan
Top clinical trial sponsors for Omiganan

See all Omiganan clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.